Moertel Cg
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- Hepatology top 10%
Papers in
- Oncology 22
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 6
-
- Gastric Cancer Management and Outcomes 13
- Metastasis and carcinoma case studies 6
- Co-authors
- Robert G. Hahn (25 shared papers)Schutt Aj (24 shared papers)Sun‐Shin Cha (1 shared paper)Susan Galandiuk (1 shared paper)Fitzgibbons Rj (1 shared paper)Pemberton Jh (1 shared paper)Wieand Hs (1 shared paper)PT Lavin (3 shared papers)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (2 papers)PubMed (51 papers)
- Partner nations
- United States
In The Last Decade
Moertel Cg
51 papers receiving 951 citations
Peers
Comparison fields: 5 of 79
- Oncology 717
- Hepatology 95
- Pulmonary and Respiratory Medicine 326
- Pathology and Forensic Medicine 171
- Surgery 300
Countries citing papers authored by Moertel Cg
This map shows the geographic impact of Moertel Cg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moertel Cg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moertel Cg more than expected).
Fields of papers citing papers by Moertel Cg
This network shows the impact of papers produced by Moertel Cg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moertel Cg. The network helps show where Moertel Cg may publish in the future.
Co-authors
The 25 scholars most cited alongside Moertel Cg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patterns of recurrence after curative resection of carcinoma of the colon and rectum. | 1992 | 360 |
| 2 | Therapy of advanced gastrointestinal cancer with the nitrosoureas. | 1973 | 44 |
| 3 | Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. | 1974 | 42 |
| 4 | Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group. | 1980 | 42 |
| 5 | Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine. | 1983 | 42 |
| 6 | CEREBELLAR ATAXIA ASSOCIATED WITH FLUORINATED PYRIMIDINE THERAPY. | 1964 | 42 |
| 7 | Phase II trial of doxorubicin therapy for advanced islet cell carcinoma. | 1982 | 41 |
| 8 | Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination. | 1983 | 29 |
| 9 | Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome. | 1986 | 29 |
| 10 | Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". | 1979 | 28 |
| 11 | Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination. | 1976 | 27 |
| 12 | Metabolic studies of delta-9-tetrahydrocannabinol in cancer patients. | 1984 | 22 |
| 13 | Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma. | 1975 | 22 |
| 14 | Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer. | 1972 | 21 |
| 15 | Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer. | 1976 | 20 |
| 16 | Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066). | 1974 | 19 |
| 17 | Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer. | 1974 | 19 |
| 18 | COMBINED 5-FLUOROURACIL AND SUPERVOLTAGE RADIATION THERAPY IN THE PALLIATIVE MANAGEMENT OF ADVANCED GASTROINTESTINAL CANCER: A PILOT STUDY. | 1964 | 19 |
| 19 | Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. | 1976 | 18 |
| 20 | The natural history of advanced gastric cancer. | 1968 | 18 |
About Moertel Cg
Moertel Cg is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Epidemiology, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer therapeutics and mechanisms (7 papers), Cancer Treatment and Pharmacology (6 papers), Metastasis and carcinoma case studies (6 papers), Cancer Research and Treatments (5 papers), Colorectal and Anal Carcinomas (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Oncology (717 citations), Hepatology (95 citations), Pulmonary and Respiratory Medicine (326 citations), Pathology and Forensic Medicine (171 citations) and Surgery (300 citations). Moertel Cg has collaborated with scholars based in United States. Frequent co-authors include Robert G. Hahn, Schutt Aj, Sun‐Shin Cha, Susan Galandiuk, Fitzgibbons Rj, Pemberton Jh, Wieand Hs, PT Lavin, O'Connell Mj and Joseph Rubin. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.